• 20S constitutive proteasome, 20S immunoproteasome, and cathepsin S are high-sensitivity and independent markers of immunological activity in relapsing-remitting type of multiple sclerosis
• A case report of pediatric-onset MS associated uveitis
• A Comprehensive Management of Devic's Disease: A Pediatric Case Study
• Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging Measures
• Absence of farnesol salvage in <em>Candida albicans</em> and probably in other fungi
• Acute disseminated encephalomyelitis in a young patient: A case report
• Adult and pediatric relapsing multiple sclerosis phase II and phase III trial design and their primary end points: A systematic review
• Advancements and challenges in CAR T cell therapy in autoimmune diseases
• An online, two-day educational seminar had no impact on disease-specific knowledge in patients with systemic sclerosis
• Antipsychotics use in autoimmune encephalitis and multiple sclerosis: Impact on hospitalization duration
• Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network
• Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis
• Astrocytic stress response is induced by exposure to astrocyte-binding antibodies expressed by plasmablasts from pediatric patients with acute transverse myelitis
• Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
• Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders
• AWMF mold guideline "Medical clinical diagnostics for indoor mold exposure" - Update 2023 AWMF Register No. 161/001
• Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
• Body size interacts with the structure of the central nervous system: A multi-center in vivo neuroimaging study
• Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?
• CD19 CAR T cells for multiple sclerosis: Forging further into the new frontier
• CD19-Directed CAR T-Cells in a Patient With Refractory MOGAD: Clinical and Immunologic Follow-Up for 1 Year
• Clinical and magnetic resonance imaging outcomes in pediatric-onset MS patients on fingolimod and ocrelizumab
• Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study
• Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation
• Clinical laboratory test utilization of CSF oligoclonal bands and IgG index in a tertiary pediatric hospital
• Clinical Profile and Outcome of Pediatric Demyelinating Disorders in Calabar, Nigeria: A Case Series
• Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein
• Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis
• Cognitive and psychopathological outcomes in acute disseminated encephalomyelitis
• Critical review of the evidence for Vojta Therapy: a systematic review and meta-analysis
• CSF sphingolipids are correlated with neuroinflammatory cytokines and differentiate neuromyelitis optica spectrum disorder from multiple sclerosis
• Delayed initiation of disease modifying therapy increases relapse frequency and motor disability in pediatric onset multiple sclerosis
• Depression and anxiety in MS: symptoms or comorbidity?
• Desmoplastic infantile astrocytoma/ ganglioglioma in a pediatric onset multiple sclerosis patient: A case report
• Detection of capillary abnormalities in early diabetic retinopathy using scanning laser ophthalmoscopy and optical coherence tomography combined with adaptive optics
• Development of an Objective Structured Clinical Examination (OSCE) to evaluate the diagnosis announcement of chronic neurological disease by residents in neurology
• Developmental origin of oligodendrocytes determines their function in the adult brain
• Diagnoses and Treatment Recommendations-Interrater Reliability of Uroflowmetry in People with Multiple Sclerosis
• Dimethyl Fumarate Mediates Sustained Vascular Smooth Muscle Cell Remodeling in a Mouse Model of Cerebral Aneurysm
• Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
• Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates
• Early Adversity and Socioeconomic Factors in Pediatric Multiple Sclerosis: A Case-Control Study
• Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020)
• Erdheim-Chester disease as complex clinical presentation and diagnosis: A case report and concise review of literature
• Evaluation of mental performance and cognitive functions of children and adolescents diagnosed with radiologically isolated syndrome
• Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma
• Ferroptosis in health and disease
• Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
• Friedreich Ataxia Caregiver-Reported Health Index: Development of a Novel, Disease-Specific Caregiver-Reported Outcome Measure
• Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?
• High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis
• Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
• Hunting the origin and source of NR1-directed IgGs in patients with encephalitis
• Identifying High-Quality Non-Instrumental Dysphagia Screening Tools for Detection of Adult Dysphagia Case in Acute-Care Settings: A Systematic Review
• Implication of Apolipoprotein E gene variants in pediatric-onset multiple sclerosis: Possible association with disease susceptibility and its clinical characteristics, in a Hellenic cohort
• Iron scavenging and myeloid cell polarization
• Knowledge mapping of disease-modifying therapy (DMT) in multiple sclerosis (MS): A bibliometrics analysis
• Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis
• Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes
• Low-field MRI for use in neurological diseases
• Lower Urinary Tract Dysfunction in Pediatric Patients with Multiple Sclerosis: Diagnostic and Management Concerns
• Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus
• Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics
• MAGinator enables accurate profiling of de novo MAGs with strain-level phylogenies
• Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis
• Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study)
• mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes
• Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex
• Multiple recurrent supraventricular tachycardia in infantile tuberous sclerosis complex: management requiring triple-drug therapy
• Nanopore DNA Sequencing Detected Chromothripsis-Induced PAFAH1B1::USP6 Rearrangement in Periosteal Solid Aneurysmal Bone Cyst Initially Diagnosed as Osteosarcoma
• No one really plans to have multiple sclerosis: Transition readiness and quality of life in paediatric multiple sclerosis
• Old and New Strategies in the Treatment of Pediatric Multiple Sclerosis: A Personal View for a New Treatment Approach
• Oral corticosteroid dosage and tapeduration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
• Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse
• Overview of Structural and Functional Insights of SLFN12 Associated With Different Diseases
• Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis
• Pediatric Autoimmune Neurologic Disorders
• Pediatric Patient With Neurofibromatosis I Presenting With Perceptual Disturbances and a Suicide Attempt
• Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
• Physiotherapy Rehabilitation for Compressive Myelopathy in a 12-Year-Old Girl: A Case Study
• Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation
• Potential of CBD Acting on Cannabinoid Receptors CB₁ and CB₂ in Ischemic Stroke
• Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease
• Prevalence of Liver Steatosis in Tuberous Sclerosis Complex Patients: A Retrospective Cross-Sectional Study
• Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
• Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases
• Respiratory functions, respiratory muscle strength and fatigue in patients with pediatric-onset multiple sclerosis: a comparative cross-sectional study
• Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis
• Sexual Health Education and Quality of Counseling in Pediatric-Onset Multiple Sclerosis
• Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration
• Structural and functional imaging features of cognitive phenotypes in pediatric multiple sclerosis
• Study of seasonality of attacks in MOG antibody-associated disease
• Successful treatment of a complete Susac syndrome in a 16-year-old boy: A case report
• The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data
• The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
• The impact of ATP-binding cassette transporters in the diseased brain: Context matters
• The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile
• Tumefactive Demyelinating Lesions: An Illustrative Pediatric Case With an Atypical Presentation and Literature Review
• Wall-Eyed Bilateral Internuclear Ophthalmoplegia as Part of the Clinical Presentation of Pediatric Multiple Sclerosis, Successfully Treated With Therapeutic Plasma Exchange
• Widespread service fragmentation for patients and families with tuberous sclerosis complex (TSC) in the Republic of Ireland